Zedsen provides biosensors that create a 3-Dimensional electrical field and gathers biological signals within a human body.
Zedsen has raised €10M across 1 funding round, most recently a Series B round in Apr 2021. Based in London, UK; founded 2014; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-04-07 | Series B | €10M |
| — |
| View deal → |
